BCI PHARMA

bci-pharma-logo

BCI Pharma designs and synthesizes kinase inhibitor libraries. They identify novel, potent, and selective kinase inhibitor hits. They develop cell-based assays. They also plan to deliver medications for inflammatory diseases, CNS disorders, and cancer. Their goal is to create a world-renowned firm that its patients, customers, investors, business partners, and the communities where they work and live regard highly.

#SimilarOrganizations #People #Financial #Website #More

BCI PHARMA

Social Links:

Industry:
Biotechnology Business Development Finance Health Care Innovation Management

Founded:
2013-01-01

Address:
Grabels, Languedoc-Roussillon, France

Country:
France

Website Url:
http://www.bci-pharma.com

Total Employee:
1+

Status:
Active

Total Funding:
3.9 M EUR

Technology used in webpage:
Google Maps ReCAPTCHA Pound Sterling ReCAPTCHA V2 French Server Location


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

cstone-pharmaceuticals-logo

CStone Pharmaceuticals

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

Current Employees Featured

dominique-surleraux_image

Dominique Surleraux
Dominique Surleraux CEO @ BCI Pharma
CEO
2013-01-01

elisabeth-picou_image

Elisabeth Picou
Elisabeth Picou Co-Founder @ BCI Pharma
Co-Founder
2013-03-01

Founder


dominique-surleraux_image

Dominique Surleraux

elisabeth-picou_image

Elisabeth Picou

Investors List

theclubdeal_image

TCD Capital (ex TheClubDeal)

TCD Capital (ex TheClubDeal) investment in Series A - BCI Pharma

Official Site Inspections

http://www.bci-pharma.com Semrush global rank: 4.63 M Semrush visits lastest month: 2.06 K

  • Host name: cluster015.ovh.net
  • IP address: 213.186.33.3
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "BCI Pharma"

BCI Pharma - Crunchbase Company Profile & Funding

Mar 12, 2018 BCI Pharma's biology laboratory develops innovative cell-based assays for pharmaceutical research. Lists Featuring This Company. Edit Lists Featuring This Company โ€ฆSee details»

Richter acquires BCI Pharma - Gedeon Richter

Jun 19, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โ€ฆSee details»

BCI Pharma Company Profile 2024: Valuation, Investors

BCI Pharma General Information Description. Operator of a biotechnology firm intended to develop an innovative chemo library and medicinal chemistry. The company's firm helps to โ€ฆSee details»

BCI PHARMA - We take care of your health - LinkedIn

BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery. We design innovative chemical libraries and our HTS platform can support your โ€ฆSee details»

Richter acquires BCI Pharma - Gedeon Richter

Jun 19, 2024 Specialty pharma transformation ... Gedeon Richter Investors Announcements Richter acquires BCI Pharma. Richter acquires BCI Pharma 19/06/2024 Business related โ€ฆSee details»

BCI Pharma - Products, Competitors, Financials, Employees, โ€ฆ

BCI Pharma is a biopharmaceutical company focused on small molecule drug discovery in the healthcare sector. The company specializes in the development of novel, potent, and selective โ€ฆSee details»

BCI Pharma - BioWin

BCI Pharma. admin January 21, 2021 March 14th, 2023. BCI Pharma is a biotech company which focuses on the discovery and development of novel, highly potent and selective kinase inhibitors. Our aim is to bring new innovative treatments โ€ฆSee details»

BCI Pharma Company Profile - Office Locations, Competitors

BCI Pharma is a biopharmaceutical company focused on small molecule drug discovery. It designs a platform to identify potent and selective kinase inhibitors. The company provides โ€ฆSee details»

Richter acquires BCI Pharma - Gedeon Richter

Jun 19, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โ€ฆSee details»

BCI Pharma Company Profile: Overview and Full News Analysis

BCI Pharma, a Liège-based biotechnology company developing innovative kinase inhibitor libraries, received โ‚ฌ3.9m in funding . It included โ‚ฌ1.9M ($2.2M) in public funding from the โ€ฆSee details»

Company overview & History - BCI PHARMA

The entry of this data is necessary for the processing of the internet userโ€™s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โ€ฆSee details»

Gedeon Richter buys BCI Pharma - The Pharmaletter

Jul 2, 2024 Hungarian drugmaker Gedeon Richter (RICHT: HB) says it has acquired BCI Pharma, a Belgium-based privately-owned biotech company, carrying out innovative research โ€ฆSee details»

Vision, Value & Strategy โ€ข BCI PHARMA

The entry of this data is necessary for the processing of the internet userโ€™s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โ€ฆSee details»

BCI Pharma - Contacts, Employees, Board Members, Advisors

BCI Pharma has 2 current employee profiles, including CEO Dominique Surleraux. Contacts. Edit Contacts Section. Job Department. Protected Content. Business Management. Non โ€ฆSee details»

Richter acquires BCI Pharma - FirstWord Pharma

Jun 21, 2024 About BCI Pharma The company has been founded in March 2013 by Dominique Surleraux and Dr. Elisabeth Picou. Supported by molecular modelling, BCI designed and โ€ฆSee details»

BCI-1446 - Drug Targets, Indications, Patents - Synapse - Patsnap

BCI-1446, Initially developed by BCI Pharma SAS, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Nervous System Diseases,Skin and โ€ฆSee details»

News - BCI PHARMA

Jun 21, 2024 The BCI PHARMA Company undertakes to keep this personal data, unless there is a legal or regulatory obligation to the contrary, for a maximum period of three years from the โ€ฆSee details»

Technology - BCI PHARMA

The entry of this data is necessary for the processing of the internet userโ€™s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โ€ฆSee details»

Pipeline - BCI PHARMA

The entry of this data is necessary for the processing of the internet userโ€™s request by the BCI PHARMA Company.BCI PHARMA undertakes to comply with the provisions of law n ° 78-17 โ€ฆSee details»

linkstock.net © 2022. All rights reserved